Contralateral parotid mean dose remains the strongest xerostomia predictor in head and neck RT
Contemporary evidence supports contralateral parotid mean dose as the most robust xerostomia predictor, with risk rising around 24–26 Gy.
Contemporary evidence supports contralateral parotid mean dose as the most robust xerostomia predictor, with risk rising around 24–26 Gy.
Adding parotid–target overlap shape features improved moderate-to-severe xerostomia prediction from AUC 0.66 to 0.78.
Surgical transfer reduced contralateral submandibular mean dose by approximately 12 Gy during bilateral IMPT without compromising target coverage.